Related news and resources
Global biopharmaceutical CEOs response to reforms introduced in Germany
In response to reforms adopted by the German government on 10 July, BCR Secretary General, and IFPMA Director General, Dr. David Reddy, said: “The legislation passed by the German government undermines the value of medical innovation, global competitiveness and patient access to new medicines. Failing to reflect the value that medicines and vaccines bring, will negatively...
Read moreStatement on PABS Instrument at the seventh meeting of the Intergovernmental Working Group (IGWG 7) on the WHO Pandemic Agreement
On 6 July 2026, IFPMA delivered a statement ahead of the seventh meeting of the Intergovernmental Working Group (IGWG 7) on the WHO Pandemic Agreement.
Read moreWIPO, IFPMA and Interpat join forces to support health innovation through IP management clinics
The World Intellectual Property Organization (WIPO), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Interpat have launched a new partnership that underlines a shared commitment to intellectual property supporting health innovation.
Read more